These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD). Scott NE; Giogha C; Pollock GL; Kennedy CL; Webb AI; Williamson NA; Pearson JS; Hartland EL J Biol Chem; 2017 Oct; 292(42):17337-17350. PubMed ID: 28860194 [TBL] [Abstract][Full Text] [Related]
3. Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity. Araujo-Garrido JL; Bernal-Bayard J; Ramos-Morales F Microorganisms; 2020 Mar; 8(3):. PubMed ID: 32131463 [TBL] [Abstract][Full Text] [Related]
4. Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli. Wong Fok Lung T; Giogha C; Creuzburg K; Ong SY; Pollock GL; Zhang Y; Fung KY; Pearson JS; Hartland EL Infect Immun; 2016 May; 84(5):1346-1360. PubMed ID: 26883593 [TBL] [Abstract][Full Text] [Related]
5. Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors. Koh E; Kim U; Cho HS Sci Rep; 2022 Nov; 12(1):19288. PubMed ID: 36369343 [TBL] [Abstract][Full Text] [Related]
6. A type III effector antagonizes death receptor signalling during bacterial gut infection. Pearson JS; Giogha C; Ong SY; Kennedy CL; Kelly M; Robinson KS; Lung TW; Mansell A; Riedmaier P; Oates CV; Zaid A; Mühlen S; Crepin VF; Marches O; Ang CS; Williamson NA; O'Reilly LA; Bankovacki A; Nachbur U; Infusini G; Webb AI; Silke J; Strasser A; Frankel G; Hartland EL Nature; 2013 Sep; 501(7466):247-51. PubMed ID: 24025841 [TBL] [Abstract][Full Text] [Related]
7. NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery. García-García A; Hicks T; El Qaidi S; Zhu C; Hardwidge PR; Angulo J; Hurtado-Guerrero R Chem Sci; 2021 Sep; 12(36):12181-12191. PubMed ID: 34667584 [TBL] [Abstract][Full Text] [Related]
8. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation. Gao X; Wang X; Pham TH; Feuerbacher LA; Lubos ML; Huang M; Olsen R; Mushegian A; Slawson C; Hardwidge PR Cell Host Microbe; 2013 Jan; 13(1):87-99. PubMed ID: 23332158 [TBL] [Abstract][Full Text] [Related]
9. NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector. Giogha C; Scott NE; Wong Fok Lung T; Pollock GL; Harper M; Goddard-Borger ED; Pearson JS; Hartland EL PLoS Pathog; 2021 Jun; 17(6):e1009658. PubMed ID: 34133469 [TBL] [Abstract][Full Text] [Related]
10. Arg-GlcNAcylation on TRADD by NleB and SseK1 Is Crucial for Bacterial Pathogenesis. Xue J; Hu S; Huang Y; Zhang Q; Yi X; Pan X; Li S Front Cell Dev Biol; 2020; 8():641. PubMed ID: 32766249 [TBL] [Abstract][Full Text] [Related]
11. Auto Arginine-GlcNAcylation Is Crucial for Bacterial Pathogens in Regulating Host Cell Death. Xue J; Pan X; Peng T; Duan M; Du L; Zhuang X; Cai X; Yi X; Fu Y; Li S Front Cell Infect Microbiol; 2020; 10():197. PubMed ID: 32432056 [TBL] [Abstract][Full Text] [Related]
12. An intra-bacterial activity for a T3SS effector. El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499 [TBL] [Abstract][Full Text] [Related]
13. SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages. Günster RA; Matthews SA; Holden DW; Thurston TLM Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069818 [TBL] [Abstract][Full Text] [Related]
14. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors. El Qaidi S; Zhu C; McDonald P; Roy A; Maity PK; Rane D; Perera C; Hardwidge PR Front Cell Infect Microbiol; 2018; 8():435. PubMed ID: 30619781 [TBL] [Abstract][Full Text] [Related]
15. Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli. Pollock GL; Oates CVL; Giogha C; Wong Fok Lung T; Ong SY; Pearson JS; Hartland EL Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28138023 [TBL] [Abstract][Full Text] [Related]
16. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Li S; Zhang L; Yao Q; Li L; Dong N; Rong J; Gao W; Ding X; Sun L; Chen X; Chen S; Shao F Nature; 2013 Sep; 501(7466):242-6. PubMed ID: 23955153 [TBL] [Abstract][Full Text] [Related]
18. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity. El Qaidi S; Wu M; Zhu C; Hardwidge PR Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307 [TBL] [Abstract][Full Text] [Related]
20. Type Three Secretion System in Attaching and Effacing Pathogens. Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]